文献速递脊柱关节炎

韩国银屑病关节炎患者癌症风险:一项全国性人群队列研究

Risk of cancer in Korean patients with psoriatic arthritis: a nationwide population-based cohort study.
PubMed 文献 · RMD Open · 2023-01-01

该研究基于韩国2010年至2021年6月的全国性人群队列,纳入新诊断银屑病关节炎(PsA)患者4688例及按年龄和性别1:10匹配的对照46880例。PsA患者总体癌症调整风险比为1.20(95%CI 1.02-1.41),但排除非黑色素瘤皮肤癌(NMSC)后不再显著(aHR 1.16,95%CI 0.98-1.37);NMSC、淋巴瘤和甲状腺癌风险升高。

要点

  • PsA患者总体癌症风险升高(aHR 1.20,95%CI 1.02-1.41),但排除NMSC后无统计学显著差异。
  • PsA患者NMSC(aHR 3.64)、淋巴瘤(aHR 2.63)和甲状腺癌(aHR 1.83)风险高于对照人群。
  • 作者建议通过详细病史和全面临床检查对PsA患者进行癌症筛查。

核心结论

  • PsA患者总体癌症风险高于一般人群(aHR 1.20,95%CI 1.02-1.41),且NMSC、淋巴瘤和甲状腺癌风险升高。

研究设计与样本

  • 韩国全国性人群队列研究,纳入2010年至2021年6月新诊断的PsA患者4688例及按年龄和性别1:10匹配的对照46880例。

主要发现

  • PsA组发生162例癌症(发病率83.2/10000人年,95%CI 70.8-97.0),对照组发生1307例(发病率66.9/10000人年,95%CI 63.3-70.6)。
  • PsA患者总体癌症aHR为1.20(95%CI 1.02-1.41);排除NMSC后aHR为1.16(95%CI 0.98-1.37),无统计学显著差异。
  • PsA患者NMSC的aHR为3.64(95%CI 1.61-8.23),淋巴瘤aHR为2.63(95%CI 1.30-5.30),甲状腺癌aHR为1.83(95%CI 1.18-2.85)。

临床怎么用

  • 作者认为,研究结果提示需要通过详细病史和全面临床检查对PsA患者进行癌症筛查。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: While many studies on the increased risk of cancer in patients with psoriasis are available, data on the risk of cancer in patients with psoriatic arthritis (PsA) are still scarce. We assessed the risk of cancer in patients with PsA in a nationwide population-based cohort in Korea. METHODS: From 2010 to June 2021, patients newly diagnosed with PsA and 1:10 age-matched and sex-matched controls were included in this study. The outcome was the incidence of overall and specific cancers. RESULTS: Total 162 cancers occurred in 4688 PsA patients (incidence rate 83.2 (95% CI 70.8 to 97.0) per 10 000 person-years) and 1307 cancers occurred in 46 880 controls (incidence rate 66.9 (95% CI 63.3 to 70.6) per 10 000 person-years). The adjusted HR (aHR) of overall cancer in PsA patients was 1.20 (95% CI 1.02 to 1.41). However, this significance disappeared when non-melanoma skin cancer (NMSC) was excluded (aHR 1.16, 95% CI 0.98 to 1.37). Among specific cancers, the risk of NMSC (aHR 3.64 (95% CI 1.61 to 8.23)), lymphoma (aHR 2.63 (95% CI 1.30 to 5.30)) and thyroid cancer (aHR 1.83 (95% CI 1.18 to 2.85)) was higher in patients with PsA than in controls. CONCLUSION: The risk of overall cancer was higher in patients with PsA than in the general population. Patients with PsA had increased risks of NMSC, lymphoma and thyroid cancer compared with the general population. Our findings suggest a need to conduct cancer screening by a detailed history and comprehensive clinical examination in patients with PsA.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Eun Y, Hwang J, Seo GH, et al. Risk of cancer in Korean patients with psoriatic arthritis: a nationwide population-based cohort study. RMD Open. 2023. PMID: 36958767. doi:10.1136/rmdopen-2022-002874

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。